Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
My Invitation to Join the Ascel Bio BOD?
Dear Dr. Marcinko,
I found your name in a search for new board directors and advisors to my company. I am president of a disease forecasting and outbreak warning company named Ascel Bio.
The Firm
My company has had tremendous technical success in developing software that can forecast infectious disease outbreaks.
We’ve invented technology that turns hospitals (specifically their electronic health records) into RADAR Stations for Infectious Disease. We’ve also invented outbreak detection and measurement technology that we use to deliver something akin to an AccuWeather style service. We have good validation with federal customers and in use in a hospital setting in Colorado. And, we’ve had some good success as well in trial use with a major EHR provider, and interest from others.
Status
But, we’re still small and are really stuck in gaining the next 10 hospital users. I’m writing because I am curious whether you might be able to offer suggestions that would help us solve the puzzle.
About Ascel Bio LLC
Ascel Bio is a private disease forecasting company founded in 2010. It is an industry pioneer with a corporate mission to halve the morbidity and mortality of infectious diseases over the next 25 years. The company uses advanced predictive systems combined with the judgment of astute clinicians in building its forecasts.
***
***
Assessment
I wanted to explain our business, seek your thoughts, and see if there might be cause for engagement. If you have a moment to speak with me, I’d be grateful for your time.
Research Reports:
Kind regards,
Ascel Bio
James Tunkey
More
Why I’m Joining the Physician Nexus Medical Advisory Board
Conclusion
I will f/u privately on this invitation. But, your thoughts and comments on the ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
- DICTIONARIES: http://www.springerpub.com/Search/marcinko
- PHYSICIANS: www.MedicalBusinessAdvisors.com
- PRACTICES: www.BusinessofMedicalPractice.com
- HOSPITALS: http://www.crcpress.com/product/isbn/9781466558731
- CLINICS: http://www.crcpress.com/product/isbn/9781439879900
- ADVISORS: www.CertifiedMedicalPlanner.org
- BLOG: www.MedicalExecutivePost.com
- FINANCE: Financial Planning for Physicians and Advisors
- INSURANCE: Risk Management and Insurance Strategies for Physicians and Advisors
Share this:
Filed under: Breaking News, iMBA, Inc., Risk Management | Tagged: Ascel Bio, Ebola Report, Global Flu Report 2014, Infectious Disease Outbreaks, James Tunkey | 9 Comments »
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 